Aberrant composition of gut microbiota of allergic infants: A target of bifidobacterial therapy at weaning?

Gut

Volumn 51, Issue 1, 2002, Pages 51-55

  Kirjavainen, Pirkka V ^a   Arvola, T ^b   Salminen, S J ^a   Isolauri, E ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; PROBIOTIC AGENT;

ALLERGY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COUNT; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCOCCUS; ESCHERICHIA COLI; FECES MICROFLORA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; INFANT; INTESTINE FLORA; LACTOBACILLUS; PRIORITY JOURNAL; SENSITIZATION; WEANING; WHEY;

ANIMALS; BACTEROIDES; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; ESCHERICHIA COLI; FECES; HUMANS; IMMUNOGLOBULIN E; INFANT; INTESTINES; MILK; PROBIOTICS; REGRESSION ANALYSIS; WEANING;

EID: 0036298165     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.1.51     Document Type: Article

References (63)

1. Probiotics: A novel approach in the management of food allergy
2. Probiotics in the management of atopic eczema
3. Increase in the population of duodenal IgA plasmocytes in axenic mice monoassociated with different living or dead bacterial strains of intestinal origin
4. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes
5. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain
6. Detection of Bifidobacterium strains that induce large quantities of IgA
7. Lactic acid bacteria in the treatment of acute rotavirus gastro-enteritis
8. The effect of oral feeding of Lactobacillus casei strain Shirota on Immunoglobulin E production in mice
9. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects
10. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures
11. Effects of orally ingested Bifidobaeterium longum on the mucosal IgA response of mice to dietary antigens
12. Comparison of antiproliferative effects of probiotic cell extracts and glucocorticoids
13. Expression of a dietary protein in E. coli renders it strongly antigenic to gut lymphoid tissue
14. Lactobacillus casei stroin GG reverses increased intestinal permeability induced by cow milk in suckling rats
15. Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes
16. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolysed with Lactobacillus casei GG-derived enzymes
17. New aspects of probiotics - A novel approach in the management of food allergy
18. The intestinal microflora in allergic Estonian and Swedish 2-year-old children
19. Distinct patterns of neonatal gut microflora in infants developing or not developing atopy
20. Allergy development and the intestinal microflora during the first year of life
21. Characterizing the composition of intestinal microflora as a prospective treatment target in inflant allergic disease
22. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction
23. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production
24. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
25. Functional food science and gastrointestinal physiology and function
26. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination
27. Endotoxins, asthma, and allergic immune responses
28. Endotoxin-induced bacterial translocation and mucosal permeability: Role of xanthine oxidase, complement activation, and macrophage products
29. Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo
30. The molecular mode of action of Clostridium perfringens enterotoxin
31. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life
32. Breast-feeding of allergic infants
33. Epidemiology of atopic dermatitis
34. Allergy to extensively hydrolysed cow milk proteins in infants: Identification and treatment with an amino acid-based formula
35. Intolerance to protein hydrolysate infant formulas: An underrecognised cause of gastrointestinal symptoms in infants
36. Elimination diet in cow's milk allergy: Risk for impaired growth in young children
37. Efficacy and safety of hydrolysed cow milk and omino acid-derived formulas in infants with cow milk allergy
38. Bovine beta-lactoglobulin levels in hydrolysed protein formulas for infant feeding
39. Severity scoring of atopic dermatitis: The SCORAD Index
40. Bifidobacteria and probiotic action
41. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotovirus
42. The ability of probiotic bacteria to bind to human intestinal mucus
43. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection
44. Effect of Lactobocillus GG yoghurt in prevention of antibiotic associated diarrhoea
45. Dose response colonisation of faeces after oral administration of Lactobacillus casei strain GG
46. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract
47. Quantitative fluorescence in situ hybridisation of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in faecal samples
48. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment
49. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridisation
50. Comparison of the plate culture technique and fluorescence in situ hybridisation using specific rRNA-based probes for the quantification of human faecal bacteria
51. Physiological state of E. coli BJ4 growing in the large intestines of streptomycin-treated mice
52. Clostridia isolated from the faeces of infants during the first year of life
53. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods
54. Regulatory effects of bifidobacteria on the growth of the other colonic bacteria
55. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions
56. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide
57. Impact of Bifidobacterium longum on human faecal microflora
58. Hypoallergenic infant formulas
59. Influence of oral colonization of the intestine with a non-enteropathogenic E. coli strain after birth on the frequency of infectious and allergic diseases after 10 and 20 years
60. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial
61. Enterococci at the crossroads of food safety?
62. Saliva composition and caries development in asthmatic patients treated with beta 2-adrenoceptor agonists: A 4-year follow-up study